Zepp Health (ZEPPN) AI Stock Analysis
Zepp Health
(BMV:ZEPPN)
No summary available
Zepp Health (ZEPPN) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- MXN 31.51M
- Dividend Yield
- ―
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- -0.0
- Beta (1Y)
- -0.66
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- Mexico
- Employees
- 763
- Sector
- Technology
- Sector Strength
- 61
- Industry
- Consumer Electronics
Zepp Health Business Overview & Revenue Model
Company Description
Headquartered in Hefei, China, and established in 2013, Zepp Health Corporation (known as Huami Corporation until its rebranding in February 2021) is a technology firm specializing in the creation, production, and sale of intelligent wearable devices...
Zepp Health Earnings Call Summary
The call was broadly optimistic, with strong 33.8% revenue growth, higher average selling prices, year-over-year gross-margin expansion, market-share gains, product launches, and progress toward profitable growth. The main challenges were near-term memory-cost pressure, foreign-exchange headwinds, continued operating and net losses, higher operating expenses, and a lower second-quarter growth range. The positive operating and strategic developments significantly outweighed the stated challenges.
Q2-2026 Updates
Positive Updates
Negative Updates
Company Guidance
For the second quarter of 26, the company expects revenue to be in the range of $63 million to $68 million, representing year over year growth of approximately 6% to 14%, supported by demand across its product portfolio while accounting for normal shipment timing and product launch phasing during the quarter; it expects to have more than 9 product launches this year, R&D expenses to trim towards the norm starting from the second half of the year, marketing expenses to average down in the second half of the year, G&A expenses to show a step down already in Q2 and going towards Q3 and Q4, and operating expenses to run at around $30 million a quarter or even lower than that, while it does not give the guidance on the full year but is looking at a profitable growth over 2025.
Zepp Health Risk Analysis
Zepp Health disclosed 72 risk factors in its most recent earnings report. Zepp Health reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
3 New RisksZepp Health Peers Comparison
Overall Rating
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 61Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
* Technology Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| MX:ZEPPN | Zepp Health Corporation | 254.00 | 184.00 | 262.86% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.